🔴 Icecure Medical is trading 5.5% down today with no clear company-specific catalyst

Icecure Medical is trading at $1.20, down -5.51%; no clear company-specific catalyst has surfaced for the October 7 decline.

• Shares fell 17.53% on October 6, closing at $1.27.
• IceCure announced October 6 that Legacy Health joined its FDA-approved ChoICE post-marketing study; available coverage does not link the update to the selloff.
• Broader risk-off conditions, including higher Treasury yields and oil prices ahead of Fed minutes, offer market context.